The United States and the European Union (EU) completed an exchange of letters to amend the Pharmaceutical Annex to the 1998 U.S.-EU Mutual Recognition Agreement. Under this agreement, U.S. and EU regulators will be able to utilize each other’s good manufacturing practice inspections of pharmaceutical manufacturing facilities.
from Food and Drug Administration--Press Releases http://ift.tt/2lh6rlY
via IFTTT
No comments:
Post a Comment